Nesfatin-1, a unique regulatory neuropeptide of the brain

Neuropeptides

Volumn 46, Issue 3, 2012, Pages 105-112

  Pałasz, Artur ^a   Krzystanek, Marek ^a   Worthington, John ^b   Czajkowska, Beata ^b   Kostro, Karol ^a   Wiaderkiewicz, Ryszard ^a   Bajor, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Anorexia; Hypothalamus; Nesfatin 1; Neuropeptides; NUCB2

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MELANOCORTIN; NESFATIN 1; NEUROPEPTIDE; OXYTOCIN; UNCLASSIFIED DRUG; VASOPRESSIN;

ANTIINFLAMMATORY ACTIVITY; ANXIETY; ARCUATE NUCLEUS; BEHAVIOR; BRAIN FUNCTION; COGNITION; DEPRESSION; DRUG MECHANISM; EATING DISORDER; EPILEPSY; FOOD INTAKE; HOMEOSTASIS; HUMAN; HYPERPOLARIZATION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IMMUNOCOMPETENT CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REPRODUCTION; REVIEW; SLEEP; STRESS; SUPRAOPTIC NUCLEUS; WEIGHT GAIN;

ANIMALS; APOPTOSIS; APPETITE; ARCUATE NUCLEUS; BRAIN; BRAIN CHEMISTRY; CALCIUM-BINDING PROTEINS; DEPRESSIVE DISORDER; DNA-BINDING PROTEINS; EATING DISORDERS; EPILEPSY; HUMANS; HYPOTHALAMUS; NERVE TISSUE PROTEINS; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; REPRODUCTION; STRESS, PSYCHOLOGICAL;

ANIMALIA;

EID: 84860654624     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2011.12.002     Document Type: Review

References (60)

1. Ari M., Ozturk O.H., Bez Y., Oktar S., Erduran D. High plasma nesfatin-1 level in patients with major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:497-500.
2. Atsuchi K., Asakawa A., Ushikai M., Ataka K., Tsai M., Koyama K., Sato Y., Kato I., Fujimiya M., Inui A. Centrally administered nesfatin-1 inhibits feeding behaviour and gastroduodenal motility in mice. NeuroReport 2010, 21:1008-1011.
3. Aydin S., Dag E., Ozkan Y., Arslan O., Koc G., Bek S., Kirbas S., Kasikci T., Abasli D., Gokcil Z., Odabasi Z., Catak Z. Time-dependent changes in the serum levels of prolactin, nesfatin-1 and ghrelin as a marker of epileptic attacks in young male patients. Peptides 2011, 32:1276-1280.
4. Aydin S., Dag E., Ozkan Y., Erman F., Dagli A.F., Kilic N., Sahin I., Karatas F., Yoldas T., Barim A.O., Kendir Y. Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol. Cell. Biochem. 2009, 328:49-56.
5. Blevins J.E., Schwartz M.W., Baskin D.G. Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R87-96.
6. Bloem B., Xu L., Morava E., Faludi G., Palkovits M., Roubos E.W., Kozicz T. Sex-specific differences in the dynamics of cocaine and amphetamine-regulated transcript and nesfatin-1 expressions in the midbrain of depressed suicide victims vs. controls. Neuropharmacology 2011, (doi:10.1016/j.neuropharm.2011.07.023).
7. Bonnet M.S., Pecchi E., Trouslard J., Jean A., Dallaporta M., Troadec J.D. Central nesfatin-1 expressing neurons are sensitive to peripheral imflammatory stimulus. J Neuroinflammation 2009, 6:27.
8. Brailoiu G.C., Dun S.L., Brailoiu E., Inan S., Yang J., Chang J.K., Dun N.J. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 2007, 148:5088-5094.
9. Chaki S., Okubo T. Melanocortin-4 receptor antagonists for the treatment of depression and anxiety disorders. Curr. Top. Med. Chem. 2007, 7:1145-1151.
10. Connan F., Lightman S.L., Landau S., Wheeler M., Treasure J., Campbell I.C. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP. J. Psychiatr. Res. 2007, 41:131-143.
11. Domschke K., Danniowski U., Hohoff C., Ohrmann P., Bauer J., Kugel H., Zwanger P., Heindel W., Deckert J., Arolt V., Suslow T., Baune B.T. Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression. Eur. Neuropsychopharmacol. 2010, 20:301-309.
12. Foo K.S., Brismar H., Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience 2008, 156:563-579.
13. Foo K.S., Brauner H., Ostenson C.G., Broberger C. Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J. Endocrinol. 2010, 204:255-263.
14. Fort P., Salvert D., Hanriot L., Jego S., Shimizu H., Hashimoto K., Mori M., Luppi P.H. The satiety molecule nesfatin-1 is co-expressed with melanin concentrating hormone in tuberal hypothalamic neurons of the rat. Neuroscience 2008, 155:174-181.
15. Garcia-Galiano D., Navarro V.M., Roa J., Ruiz-Pino F., Sanchez-Garrido M.A., Pineda R., Castellano J.M., Romero M., Aguilar E., Gaytan F., Dieguez C., Pinilla L., Tena-Sempere M. The anorexigenic neuropeptide, nesfatin-1, is indispensable for normal puberty onset in the female rat. J. Neurosci. 2010, 30:7783-7792.
16. Garcia-Galiano D., Navarro V.M., Gaytan F., Tena-Sempere M. Expanding roles of NUCB2/nesfatin-1 in neuroendocrine regulation. J. Mol. Endocrinol. 2010, 45:281-290.
17. Goebel M., Stengel A., Wang L., Lambrecht N.W., Taché Y. Nesfatin-1 immunoreactivity in rat brain and spinal cord autonomic nuclei. Neurosci. Lett. 2009, 452:241-246.
18. Goebel-Stengel M., Wang L., Stengel A., Tache Y. Localization of nesfatin-1 neurons in the mouse brain and functional implication. Brain Res. 2011, 1396:20-34.
19. Gonzalez R., Reingold B.K., Gao X., Gaidhu M.P., Tsushima R.G., Uniappan S. Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet β- and MIN6 cells. J. Endocrinol. 2011, 208:R9-R16.
20. Gonzalez R., Kerbel B., Chun A., Uniappan S. Molecular, cellular and physiological evidences for anorexigenic actions of nesfatin-1 in goldfish. PLoS ONE 2010, 5:e15201.
21. Heymsfield S.B., Greenberg A.S., Fujioka K., Dixon R.M., Kushner R., Hunt T., Lubina J.A., Patane J., Self B., Hunt P., McCamish M. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999, 282:1568-1575.
22. Inhoff T., Stengel A., Peter L., Goebel M., Taché Y., Bannert N., Wiedenmann B., Klapp B.F., Mönnikes H., Kobelt P. Novel insight in distribution of nesfatin-1 and phospho-mTOR in the arcuate nucleus of the hypothalamus of rats. Peptides 2010, 31:257-262.
23. Inhoff T., Mönnikes H., Noetzel S., Stengel A., Goebel M., Dinh Q.T., Riedl A., Bannert N., Wisser A.S., Wiedenmann B., Klapp B.F., Taché Y., Kobelt P. Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides 2008, 29:2159-2168.
24. Iwasaki Y., Nakabayashi H., Kakei M., Shimizu H., Mori M., Yada T. Nesfatin-1 evokes Ca2+ signaling in isolated vagal afferent neurons via Ca2+ influx through N-type channels. Biochem. Biophys. Res. Commun. 2009, 390:958-962.
25. Liu Z., Wang F., Li Z.Z., Qi J.H., Xu W.Z., Zhang P.S., Sun T. Expression of neuropeptides ghrelin and nesfatin-1 in kainic acid kindling rats. Zhonghua. Yi. Xue. Za. Zhi. 2011, 91:496-500.
26. Kishi T., Aschkenasi C.J., Lee C.E., Mountjoy K.G., Saper C.B., Elmquist J.K. Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J. Comp. Neurol. 2003, 457:213-235.
27. Kohno D., Nakata M., Maejima Y., Shimizu H., Sedbazar U., Yoshida N., Dezaki K., Onaka T., Mori M., Yada T. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 2008, 149:1295-1301.
28. Könczöl K., Bodnar I., Zelena D., Pinter O., Papp R.S., Palkovits M., Nagy G.M., Toth Z.E. Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic-pituitary-adrenal axis in rats. Neurochem. Int. 2010, 53:189-197.
29. Maejima Y., Sedbazar U., Suyama S., Kohno D., Onaka T., Takano E., Yoshida N., Koike M., Uchiyama Y., Fujiwara K., Yashiro T., Horvath T.L., Dietrich M.O., Tanaka S., Dezaki K., Oh-I S., Hashimoto K., Shimizu H., Nakata M., Mori M., Yada T. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab. 2009, 10:355-365.
30. Merali Z., Cayer C., Kent P., Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology (Berl) 2008, 201:115-123.
31. 2+ influx through L-type channels in mouse b-cells. Endocr. J. 2011, 58:305-313.
32. Noetzel S., Stengel A., Inhoff T., Goebel M., Wisser A.S., Bannert N., Wiedenmann B., Klapp B.F., Tache Y., Mönnikes H., Kobelt P. CCK-8S activates c-Fos in a dose-dependent manner in nesfatin-1 immunoreactive neurons in the paraventricular nucleus of the hypothalamus and in the nucleus of the solitary tract in the brain stem. Regul. Pept. 2009, 157:84-91.
33. Oh I.S., Shimizu H., Satoh T., Okada S., Adachi S., Inoue K., Eguchi H., Yamamoto M., Imaki T., Hashimoto K., Tsuchiya T., Monden T., Horiguchi K., Yamada M., Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006, 443:709-712.
34. Ogiso K., Asakawa A., Amitani H., Nakahara T., Ushikai M., Haruta I., Koyama K.-I., Amitani M., Harada T., Yasuhara D., Inui A. Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa. Peptides 2011, 32:150-153.
35. Okere B., Xu L., Roubos E.W., Sonetti D., Kozicz T. Restraint stress alters the secretory activity of neurons co-expressing urocortin-1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 in the mouse Edinger-Westphal nucleus. Brain Res. 2010, 1317:92-99.
36. Ozaki Y., Onaka T., Nakazato M., Saito J., Kanemoto K., Matsumoto T., Ueta Y. Centrally administered neuromedin U activates neurosecretion and induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat. Endocrinology 2002, 143:4320-4329.
37. Özsavci D., Ersahin M., Sener A., Özakpinar Ö.B., Toklu H.Z., Akakin D., Sener G., Yegen B.C. The novel function of nesfatin-1 as an anti-inflammatory and antiapoptotic peptide in subarachnoid hemorrhage-induced oxidative brain damage in rats. Neurosurgery 2011, 68:1699-1708.
38. Pałasz A., Bryzek A., Krzystanek M., Wiaderkiewicz R. Anoreksygenna aktywnosc nesfatyny-1 w jadrach podwzgórza i jej potencjalne implikacje kliniczne/Anorexigenic activity of nesfatin-1 in hypothalamic nuclei and its potential clinical implications. Farmakoter. Psychiatr. Neurol. 2010, 26:39-43.
39. Pan W., Hsuchou H., Kastin A.J. Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides 2007, 28:2223-2228.
40. Price C.J., Samson W.K., Ferguson A.V. Nesfatin-1 inhibits NPY neurons in the arcuate nucleus. Brain Res. 2008, 1230:99-106.
41. Ramanjaneya M., Chen J., Brown J.E., Tripathi G., Hallschmid M., Patel S., Kern W., Hillhouse E.W., Lehnert H., Tan B.K., Randeve H.S. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 2010, 151:3169-3180.
42. Sabatier N. Alpha-Melanocyte-stimulating hormone and oxytocin: a peptide signalling cascade in the hypothalamus. J. Neuroendocrinol. 2006, 18:703-710.
43. Saldanha J.F., Carrero J.J., Mafra D. The possible role of nesfatin-1 on appetite regulation in hemodialysis patients. Med. Hypotheses 2011, (doi:10.1016/j.mehy.2011.07.006).
44. Stengel A., Goebel M., Wang L., Rivier J., Kobelt P., Mönnikes H., Lambrecht N.W., Taché Y. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology 2009, 150:4911-4919.
45. Stengel A., Goebel M., Wang L., Tache Y. Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight. Peptides 2010, 31:357-369.
46. Stengel A., Goebel M., Tache Y. Nesfatin-1: a novel inhibitory regulator of food intake and body weight. Obesity Rev. 2010, 12:261-271.
47. Stengel A., Goebel M., Wang L., Tache Y. Abdominal surgery activates nesfatin-1 immunoreactive brain nuclei in rats. Peptides 2010, 31:263-270.
48. Stengel A., Tache Y. Nesfatin-1: role as a possible new potent regulator of food intake. Regul. Pept. 2010, 9:18-23.
49. Stengel A., Tache Y. Minireview: Nesfatin-1 an emerging new player in the brain-gut, endocrine and metabolic axis. Endocrinology 2011, (doi:10.1210/en.2011-1500).
50. Shimizu H., Oh I.S., Okada S., Mori M. Nesfatin-1: an overview and future clinical application. Endocr. J. 2009, 56:537-543.
51. Singru P.S., Sánchez E., Fekete C., Lechan R.M. Importance of melanocortin signaling in refeeding-induced neuronal activation and satiety. Endocrinology 2007, 148:638-646.
52. Su Y., Zhang J., Tang Y., Bi F., Liu J.N. The novel function of nesfatin-1: anti-hyperglycemia. Biochem. Biophys. Res. Commun. 2010, 391:1039-1042.
53. Tadross J.A., Patterson M., Wynne K.J., Patel S., Suzuki K., Ghatei M.A., Bloom S.R. Nesfatin supresses feeding and stimulates the hypothalamo-pituitary-gonadal axis. Endocr. J. 2010, 57:S355-S648.
54. Tan B.K., Hallschmid M., Kern W., Lehnert H., Randeva H.S. Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2 in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment. J. Clin. Endocrinol. Metab. 2011, 96:E669-E673.
55. Tanida M., Mori M. Nesfatin-1 stimulates renal sympathetic nerve activity in rats. NeuroReport 2011, 22:309-312.
56. Tsuchiya T., Shimizu H., Yamada M., Osaki A., Oh I.S., Ariyama Y., Takahashi H., Okada S., Hashimoto K., Satoh T., Kojima M., Mori M. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin. Endocrinol. 2010, 73:484-490.
57. Yoshida N., Maejima Y., Sedbazar U., Ando A., Kurita H., Damdindorj B., Takano E., Gantulga D., Iwasaki Y., Kurashina T., Onaka T., Dezaki K., Nakata M., Mori M., Yada T. Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis. Aging 2010, 2:775-784.
58. Yosten G.L.C., Samson W.K. Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R1330-R1336.
59. Yosten G.L.C., Samson W.K. The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298:R1642-R1647.
60. Zhang A.Q., Li X.L., Jiang C.Y., Lin L., Shi R.H., Chen J.D., Oomura Y. Expression of nesfatin-1/NUCB2 in rodent digestive system. World J. Gastroenterol. 2010, 16:1735-1741.